
Wednesday, January 04, 2023 9:33:09 AM
Recent CMMB News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 06/23/2025 09:06:15 PM
- Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 06/11/2025 12:00:00 PM
- Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 06/03/2025 12:00:00 PM
- Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/15/2025 12:00:00 PM
- Chemomab Announces Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis in Distinguished Plenary Session at DDW 2025 • GlobeNewswire Inc. • 05/05/2025 12:00:00 PM
- Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases • GlobeNewswire Inc. • 04/28/2025 12:00:00 PM
- Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences • GlobeNewswire Inc. • 04/21/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2025 12:00:43 PM
- Chemomab Announces New Medical and Clinical Appointments • GlobeNewswire Inc. • 04/15/2025 12:00:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/04/2025 09:17:33 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2025 12:30:11 PM
- Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers • GlobeNewswire Inc. • 03/27/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/20/2025 09:14:19 PM
- New Data Presented at CORA 2025 Conference Highlights Clinical Potential of Chemomab’s Nebokitug in Systemic Sclerosis • GlobeNewswire Inc. • 03/06/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/03/2025 01:00:11 PM
- Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 03/03/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/19/2025 12:00:22 PM
- Chemomab Completes Successful End-of-Phase 2 Meeting and Aligns with FDA on Clear and Efficient Path to Potential Regulatory Approval for Nebokitug (CM-101) in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 02/19/2025 12:00:00 PM
- Chemomab Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/03/2025 12:00:00 PM
- Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit • GlobeNewswire Inc. • 12/03/2024 12:00:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/02/2024 09:22:12 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/29/2024 08:04:59 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/21/2024 03:59:28 PM
- Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis • GlobeNewswire Inc. • 11/19/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/18/2024 09:19:07 PM
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts • ABX • Jun 23, 2025 8:45 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM